volume 58, issue 7, P667-700 2014
DOI: 10.1590/0004-2730000003427
View full text
|
Sign up to set email alerts
|
Share

Abstract: ABSTRACTIntroduction: Medullary thyroid carcinoma (MTC) originates in the thyroid parafollicular cells and represents 3-4% of the malignant neoplasms that affect this gland. Approximately 25% of these cases are hereditary due to activating mutations in the REarranged during Transfection (RET) proto-oncogene. The course of MTC is indolent, and survival rates depend on the tumor stage at diagnosis. The present article describes clinical evidence-based guidelines for the diagnosis, treatment, and follow-up of MT…

Expand abstract